Global PVQ SE
Q-Cells SE: Joint Representative Resign from Office
Q-Cells SE / Key word(s): Bond Convenience Translation For information purposes only Q-Cells International Finance B.V. Rotterdam, The Netherlands EUR 492.500.000 1,375 % convertible blonds due 2012 ISIN: DE000A0LMY64 / WKN: A0LMY6 With the unconditional and irrevocable guarantee of Q-Cells SE, Bitterfeld-Wolfen, Germany Notice; I. Declaration of Dr. Carlos Mack Dr. Carlos Mack, attorney-at-law, Wiedenmayerstraße 29, 80358 Munich, Germany the following: 'I, Dr. Carlos Mack, Wiedenmayerstraße 29, 80358 Munich, Germany, declare towards the holders of the partial bonds forming part of the convertible bond issued by Q-Cells International Finance B.V., Rotterdam, The Netherlands, in the total amount of EUR 492.500.000 (1,375 %) due 2012, with the unconditional and irrevocable guarantee of Q-Cells SE, Bitterfeld-Wolfen, Germany (ISIN: DE000A0LMY64 / WKN: A0LMY6) (the convertible bond hereinafter the 'Bond', the holders of the partial bonds hereinafter the 'Creditors') the following: I refer to the resolution of the holders' meeting of 25 October 2011 to appoint me joint representative of the Creditors. Herewith, I resign from my office as joint representative with immediate effect. I advise that Dr. Tom Oliver Schorling, who, pursuant to the resolution of the holders' meeting of 25 October 2011, was appointed as joint representative in case of the end of my office as joint representative, intends to resign from his office today as well. I advise also to the notices made in connection with the resolution of the Local Court of Dessau-Roßlau of 1 July 2012, with which the court opened the insolvency proceedings over the assets of Q-Cells SE, set a time-limit of the filing of the insolvency claims and determined hearings in the insolvency proceedings for 18 July 2012 and 15 August 2012. Dr. Carlos Mack' II. Declaration of Dr. Tom Oliver Schorling Dr. Tom Oliver Schorling,, attorney-at-law, c/o White & Case LLP, Maximilianstraße 35, 80539 München, Deutschland, declared to Q-Cells International Finance B.V. the following: 'I, Dr. Tom Oliver Schorling , c/o White & Case LLP, Maximilianstraße 35, 80539 Munich, Germany, declare towards the holders of the partial bonds forming part of the convertible bond issued Q-Cells International Finance B.V., Rotterdam, The Netherlands, in the total amount of EUR 492.500.000 (1,375 %) due 2012, with the unconditional and irrevocable guarantee of Q-Cells SE, Bitterfeld-Wolfen, Germany (ISIN: DE000A0LMY64 / WKN: A0LMY6) (the convertible bond hereinafter the 'Bond', the holders of the partial bonds hereinafter the 'Creditors'). the following: I refer to the resolution of the holders' meeting of 25 October 2011 to appoint Dr. Carlos Mack as joint representative of the Creditors and myself to appoint as joint representative of the Creditors in case that the office of Dr. Carlos Mack as joint representative ends by way of resignation or in any other manner (except the withdrawal by way of majority resolution of the Creditors). Dr. Carlos Mack declared today to resign from his office as joint representative with immediate effect. Herewith, I resign from my office as joint representative with immediate effect. I advise also to the notices made in connection with the resolution of the Local Court of Dessau-Roßlau of 1 July 2012, with which the court opened the insolvency proceedings over the assets of Q-Cells SE, set a time-limit of the filing of the insolvency claims and determined hearings in the insolvency proceedings for 18 July 2012 and 15 August 2012. Dr. Tom Oliver Schorling' End of Corporate News 01.08.2012 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
Language: | English | |
Company: | Q-Cells SE | |
Sonnenallee 17-21, OT Thalheim | ||
06766 Bitterfeld-Wolfen | ||
Germany | ||
Phone: | +49 (0)3494 – 6699-0 | |
Fax: | +49 (0)3494 – 6699-199 | |
E-mail: | q-cells@q-cells.com | |
Internet: | www.q-cells.com | |
ISIN: | DE0005558662, Wandelanleihe 2012: DE000A0LMY64, Wandelanleihe 2014: DE000A1AGZ06, Wandelanleihe 2015: DE000A1E8HF6 | |
WKN: | 555866 | |
Listed: | Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart | |
End of News | DGAP News-Service |
179905 01.08.2012 |